JP2009517386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009517386A5 JP2009517386A5 JP2008542377A JP2008542377A JP2009517386A5 JP 2009517386 A5 JP2009517386 A5 JP 2009517386A5 JP 2008542377 A JP2008542377 A JP 2008542377A JP 2008542377 A JP2008542377 A JP 2008542377A JP 2009517386 A5 JP2009517386 A5 JP 2009517386A5
- Authority
- JP
- Japan
- Prior art keywords
- aag
- pharmaceutical suspension
- phosphatidylcholine
- ester
- block copolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007971 pharmaceutical suspension Substances 0.000 claims 8
- 150000002148 esters Chemical class 0.000 claims 5
- 238000009472 formulation Methods 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 5
- 229920001400 block copolymer Polymers 0.000 claims 4
- 229920001214 Polysorbate 60 Polymers 0.000 claims 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims 3
- 239000000194 fatty acid Substances 0.000 claims 3
- 229930195729 fatty acid Natural products 0.000 claims 3
- 150000004665 fatty acids Chemical class 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 239000004094 surface-active agent Substances 0.000 claims 3
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73922505P | 2005-11-23 | 2005-11-23 | |
| US80952706P | 2006-05-30 | 2006-05-30 | |
| US11/595,005 US7648976B2 (en) | 2005-11-23 | 2006-11-08 | 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations |
| PCT/US2006/044746 WO2007061878A2 (en) | 2005-11-23 | 2006-11-16 | 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009517386A JP2009517386A (ja) | 2009-04-30 |
| JP2009517386A5 true JP2009517386A5 (enExample) | 2010-01-07 |
Family
ID=38067791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542377A Abandoned JP2009517386A (ja) | 2005-11-23 | 2006-11-16 | １７−アリルアミノ−１７−デメトキシゲルダナマイシン多形体及び製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7648976B2 (enExample) |
| EP (1) | EP1951223A4 (enExample) |
| JP (1) | JP2009517386A (enExample) |
| KR (1) | KR20080089357A (enExample) |
| AU (1) | AU2006318771A1 (enExample) |
| BR (1) | BRPI0618873A2 (enExample) |
| CA (1) | CA2629196A1 (enExample) |
| WO (1) | WO2007061878A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090042847A1 (en) * | 2005-11-23 | 2009-02-12 | Kosan Biosciences Incorporated | 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations |
| US20070167422A1 (en) * | 2006-01-18 | 2007-07-19 | Yu Kwok S | Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin |
| GB0612928D0 (en) * | 2006-06-29 | 2006-08-09 | Ucb Sa | Biological products |
| JP2010516282A (ja) * | 2007-01-26 | 2010-05-20 | コーサン バイオサイエンシーズ， インコーポレイテッド | 工学的生合成によるマクロラクタム |
| US20090258869A1 (en) * | 2008-02-08 | 2009-10-15 | The Regents Of The University Of California | Methods and compounds for treatment or prevention of substance-related disorders |
| MX2019000342A (es) * | 2016-07-08 | 2019-09-04 | Ranedis Pharmaceuticals Llc | Composiciones y metodos para tratar y/o prevenir enfermedades de almacenamiento lisosomal y otras enfermedades metabolicas monogeneticas. |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261989A (en) | 1979-02-19 | 1981-04-14 | Kaken Chemical Co. Ltd. | Geldanamycin derivatives and antitumor drug |
| US5932566A (en) | 1994-06-16 | 1999-08-03 | Pfizer Inc. | Ansamycin derivatives as antioncogene and anticancer agents |
| US5662883A (en) | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
| US5534270A (en) | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
| US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
| US6682758B1 (en) | 1998-12-22 | 2004-01-27 | The United States Of America As Represented By The Department Of Health And Human Services | Water-insoluble drug delivery system |
| JP4213472B2 (ja) | 2001-03-30 | 2009-01-21 | アメリカ合衆国 | ゲルダナマイシン誘導体及びそれを用いる癌の治療方法 |
| US20040138160A1 (en) | 2001-04-27 | 2004-07-15 | Kenichiro Naito | Preventive/therapeutic method for cancer |
| US6872715B2 (en) | 2001-08-06 | 2005-03-29 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
| ATE387198T1 (de) | 2001-09-24 | 2008-03-15 | Conforma Therapeutic Corp | Verfahren zur herstellung von 17-allyl-amino- geldanamycin (17-aag) und anderer ansamycine |
| US20060014730A1 (en) | 2002-04-10 | 2006-01-19 | Conforma Therapeutics Corporation | Ansamycin formulations and methods for producing and using same |
| US20060148776A1 (en) | 2003-03-13 | 2006-07-06 | Conforma Therapeutics Corporation | Drug formulations having long and medium chain triglycerides |
| US20050043233A1 (en) | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| US20050020557A1 (en) | 2003-05-30 | 2005-01-27 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors |
| US20050054589A1 (en) | 2003-05-30 | 2005-03-10 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics |
| US20050020534A1 (en) | 2003-05-30 | 2005-01-27 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites |
| US20050020556A1 (en) | 2003-05-30 | 2005-01-27 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes |
| US20050026893A1 (en) | 2003-05-30 | 2005-02-03 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants |
| US20050054625A1 (en) | 2003-05-30 | 2005-03-10 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors |
| US7691838B2 (en) | 2003-05-30 | 2010-04-06 | Kosan Biosciences Incorporated | Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics |
| US6887993B1 (en) | 2003-11-12 | 2005-05-03 | Kosan Biosciences, Inc. | 11-O-methylgeldanamycin compounds |
| US20050256097A1 (en) | 2004-05-11 | 2005-11-17 | Kosan Biosciences, Inc. | Pharmaceutical solution formulations containing 17-AAG |
| WO2006034147A2 (en) | 2004-09-16 | 2006-03-30 | Abraxis Bioscience, Inc. | Compositions and methods for the preparation and administration of poorly water soluble drugs |
| US20060067953A1 (en) | 2004-09-29 | 2006-03-30 | Conforma Therapeutics Corporation | Oral pharmaceutical formulations and methods for producing and using same |
| CA2596867A1 (en) | 2005-02-28 | 2006-09-08 | Kosan Biosciences Incorporated | Pharmaceutical formulations containing 17-allylamino-17-demethoxygeldanamycin |
| BRPI0608661A2 (pt) * | 2005-04-07 | 2010-01-19 | Conforma Therapeutics Corp | formulaÇço farmacÊutica, uso de formulaÇço farmacÊutica, e, mÉtodo de preparaÇço de uma formulaÇço farmacÊutica |
-
2006
- 2006-11-08 US US11/595,005 patent/US7648976B2/en not_active Expired - Fee Related
- 2006-11-16 EP EP06837958A patent/EP1951223A4/en not_active Withdrawn
- 2006-11-16 JP JP2008542377A patent/JP2009517386A/ja not_active Abandoned
- 2006-11-16 KR KR1020087015304A patent/KR20080089357A/ko not_active Withdrawn
- 2006-11-16 CA CA002629196A patent/CA2629196A1/en not_active Abandoned
- 2006-11-16 WO PCT/US2006/044746 patent/WO2007061878A2/en not_active Ceased
- 2006-11-16 AU AU2006318771A patent/AU2006318771A1/en not_active Abandoned
- 2006-11-16 BR BRPI0618873A patent/BRPI0618873A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100003332A1 (en) | Process For Preparing Powder Comprising Nanoparticles of Sparingly Soluble Drug | |
| JP2011037876A5 (enExample) | ||
| JP2009512663A5 (enExample) | ||
| WO2012051426A3 (en) | Aggregate nanoparticulate medicament formulations, manufacture and use thereof | |
| NZ592383A (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
| JP2010510241A5 (enExample) | ||
| JP2010241820A (ja) | 保護被膜を有する再分散性超微粒状フィルムマトリックス | |
| RU2009128206A (ru) | Содержащая ревапразан твердая дисперсия и способ ее получения | |
| JP2013542945A5 (enExample) | ||
| JP2023040147A (ja) | インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法 | |
| JP2016513625A5 (enExample) | ||
| JP2020073564A5 (enExample) | ||
| JP2013505233A5 (enExample) | ||
| JP2011506587A5 (enExample) | ||
| US10596263B2 (en) | Pazopanib formulation | |
| JP2009517386A5 (enExample) | ||
| JP3881640B2 (ja) | ロラタジンを含むドライシロップ剤 | |
| KR101730865B1 (ko) | 레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법 | |
| JP2008013480A (ja) | 薬物含有微粒子およびその製造方法 | |
| WO2012002547A1 (ja) | ボセンタン固体分散体 | |
| JP5297194B2 (ja) | 初期溶解率が改善されたプランルカスト固体分散体の薬剤学的組成物およびその製造方法 | |
| CN102048702B (zh) | 一种联苯双酯纳米结晶制剂及其制备方法 | |
| US20180250227A1 (en) | Nanosuspension formulation | |
| JPH107558A (ja) | 溶解性改善製剤 | |
| JP2008522972A5 (enExample) |